Loading clinical trials...
Loading clinical trials...
Phase II Study of Evaluation of Fractionated Radio-immunotherapy With 90Y-DOTA-hLL2 as a Consolidation Therapy After First Line of Chemotherapy in Patients Older Than 60 With Disseminated Diffuse Large B-cell Lymphoma
Conditions
Interventions
90Y-DOTA-hLL2
Locations
1
France
Chu/Clcc Nantes
Nantes, France
Start Date
October 1, 2007
Primary Completion Date
March 1, 2016
Completion Date
April 1, 2018
Last Updated
April 27, 2018
NCT05139017
NCT06026319
NCT05442515
NCT01804686
NCT05755087
NCT06045247
Lead Sponsor
French Innovative Leukemia Organisation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions